Nuepro

Nuepro

On March 20, 2008, UCB recalled Neupro, its Parkinson’s drug, in the United States and some batches from Europe after finding clinical performance of market samples did not meet necessary requirements. UCB’s actions concerning Neupro are not the result of contamination or toxicity.

Source: Philip Blenkinsop, “UCB recalls Parkinson’s patch, reviews 2008 outlook,” Reuters, March 20, 2008 (http://www.reuters.com/article/healthNews/idUSL2015704120080320?feedType=RSS&feedName=healthNews).